![San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce](https://c8.alamy.com/comp/PW5TY8/san-polo-di-torrile-italy-12th-october-2018-managers-and-workers-of-gsk-and-italian-authorities-inaugurate-the-new-plant-to-produce-fostemsavir-innovative-drug-for-treatment-resistant-hiv-patients-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW5TY8.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce
![San Polo Di Torrile, Italy - October 12, 2018: Sunight Is Enlightening GSK Logo On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture And Royalty San Polo Di Torrile, Italy - October 12, 2018: Sunight Is Enlightening GSK Logo On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture And Royalty](https://previews.123rf.com/images/gonewiththewind/gonewiththewind1810/gonewiththewind181000578/110218255-san-polo-di-torrile-italy-october-12-2018-sunight-is-enlightening-gsk-logo-on-plant-for-fostemsavir-.jpg)
San Polo Di Torrile, Italy - October 12, 2018: Sunight Is Enlightening GSK Logo On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture And Royalty
![San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist](https://c8.alamy.com/comp/PW64GP/san-polo-di-torrile-italy-12th-october-2018-gsk-and-viiv-flags-waving-together-in-san-polo-di-torrile-plant-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64GP.jpg)
San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist
![EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Stock Photo - Image of viiv, italian: 128728898 EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Stock Photo - Image of viiv, italian: 128728898](https://thumbs.dreamstime.com/z/san-polo-di-torrile-italy-october-sunight-enlightening-gsk-logo-plant-fostemsavir-innovative-anti-hiv-drug-day-128728898.jpg)
EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Stock Photo - Image of viiv, italian: 128728898
![San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce](https://c8.alamy.com/comp/PW5TY5/san-polo-di-torrile-italy-12th-october-2018-managers-and-workers-of-gsk-and-italian-authorities-inaugurate-the-new-plant-to-produce-fostemsavir-innovative-drug-for-treatment-resistant-hiv-patients-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW5TY5.jpg)